| Gene symbol | MUC1 | Synonyms | ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q22 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mucin 1, cell surface associated | ||||
| GTO ID | GTC0437 |
| Trial ID | NCT03525782 |
| Disease | Lung Malignant Neoplasm | Lung Non-Small Cell Carcinoma |
| Altered gene | MUC1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MUC-1 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC |
| Year | 2018 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Guangdong Pharmaceutical University |
| Other ID(s) | 2018-006 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||||
|
|||||||||||||||